These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17324265)

  • 21. Parkin variants in North American Parkinson's disease: cases and controls.
    Lincoln SJ; Maraganore DM; Lesnick TG; Bounds R; de Andrade M; Bower JH; Hardy JA; Farrer MJ
    Mov Disord; 2003 Nov; 18(11):1306-11. PubMed ID: 14639672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A new point mutation on exon 2 of parkin gene in Parkinson's disease].
    Xu Y; Liu Z; Wang Y; Tao E; Chen G; Chen B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):409-11. PubMed ID: 12362318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exon dosage analysis of parkin gene in Chinese sporadic Parkinson's disease.
    Guo JF; Dong XL; Xu Q; Li N; Yan XX; Xia K; Tang BS
    Neurosci Lett; 2015 Sep; 604():47-51. PubMed ID: 26240990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence of PARK2 mutations in a never-smoker population with Parkinson's disease in North India.
    Prabhakar S; Vinish M; Das CP; Anand A
    Neuroepidemiology; 2010 Aug; 35(2):152-9. PubMed ID: 20571283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel parkin mutations detected in patients with early-onset Parkinson's disease.
    Bertoli-Avella AM; Giroud-Benitez JL; Akyol A; Barbosa E; Schaap O; van der Linde HC; Martignoni E; Lopiano L; Lamberti P; Fincati E; Antonini A; Stocchi F; Montagna P; Squitieri F; Marini P; Abbruzzese G; Fabbrini G; Marconi R; Dalla Libera A; Trianni G; Guidi M; De Gaetano A; Boff Maegawa G; De Leo A; Gallai V; de Rosa G; Vanacore N; Meco G; van Duijn CM; Oostra BA; Heutink P; Bonifati V;
    Mov Disord; 2005 Apr; 20(4):424-431. PubMed ID: 15584030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining the ends of Parkin exon 4 deletions in two different families with Parkinson's disease.
    Clarimon J; Johnson J; Dogu O; Horta W; Khan N; Lees AJ; Hardy J; Singleton A
    Am J Med Genet B Neuropsychiatr Genet; 2005 Feb; 133B(1):120-3. PubMed ID: 15635662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PARK2 gene mutations in early onset Parkinson's disease patients of South India.
    Padmaja MV; Jayaraman M; Srinivasan AV; Srisailapathy CR; Ramesh A
    Neurosci Lett; 2012 Aug; 523(2):145-7. PubMed ID: 22766139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A consanguineous Turkish family with early-onset Parkinson's disease and an exon 4 parkin deletion.
    Dogu O; Johnson J; Hernandez D; Hanson M; Hardy J; Apaydin H; Özekmekçi S; Sevim S; Gwinn-Hardy K; Singleton A
    Mov Disord; 2004 Jul; 19(7):812-816. PubMed ID: 15254940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of exon dosage using MLPA in South African Parkinson's disease patients.
    Keyser RJ; Lombard D; Veikondis R; Carr J; Bardien S
    Neurogenetics; 2010 Jul; 11(3):305-12. PubMed ID: 20013014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease.
    Bardien S; Keyser R; Yako Y; Lombard D; Carr J
    Parkinsonism Relat Disord; 2009 Feb; 15(2):116-21. PubMed ID: 18514563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the parkin deletion in sporadic and familial Parkinson's disease. Short communication.
    Krüger R; Vieira-Säcker AM; Kuhn W; Müller T; Woitalla D; Schöls L; Przuntek H; Epplen JT; Riess O
    J Neural Transm (Vienna); 1999; 106(2):159-63. PubMed ID: 10226936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism.
    Hedrich K; Kann M; Lanthaler AJ; Dalski A; Eskelson C; Landt O; Schwinger E; Vieregge P; Lang AE; Breakefield XO; Ozelius LJ; Pramstaller PP; Klein C
    Hum Mol Genet; 2001 Aug; 10(16):1649-56. PubMed ID: 11487568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease.
    Hertz JM; Ostergaard K; Juncker I; Pedersen S; Romstad A; Møller LB; Güttler F; Dupont E
    Eur J Neurol; 2006 Apr; 13(4):385-90. PubMed ID: 16643317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.
    Sun M; Latourelle JC; Wooten GF; Lew MF; Klein C; Shill HA; Golbe LI; Mark MH; Racette BA; Perlmutter JS; Parsian A; Guttman M; Nicholson G; Xu G; Wilk JB; Saint-Hilaire MH; DeStefano AL; Prakash R; Williamson S; Suchowersky O; Labelle N; Growdon JH; Singer C; Watts RL; Goldwurm S; Pezzoli G; Baker KB; Pramstaller PP; Burn DJ; Chinnery PF; Sherman S; Vieregge P; Litvan I; Gillis T; MacDonald ME; Myers RH; Gusella JF
    Arch Neurol; 2006 Jun; 63(6):826-32. PubMed ID: 16769863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between early-onset Parkinson's disease and mutations in the parkin gene.
    Lücking CB; Dürr A; Bonifati V; Vaughan J; De Michele G; Gasser T; Harhangi BS; Meco G; Denèfle P; Wood NW; Agid Y; Brice A; ;
    N Engl J Med; 2000 May; 342(21):1560-7. PubMed ID: 10824074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetic study of a Parkinson's disease pedigree caused by compound heterozygous mutations in PARK2 gene].
    Chen M; Cen Z; Chen Y; Zheng X; Xie F; Chen S; Luo W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Dec; 35(6):815-818. PubMed ID: 30512153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Exon rearrangement analysis of parkin gene in patients with isolated early-onset parkinsonism using semi-quantitative PCR].
    Guo JF; Tang BS; Li J; Zhang YH; Zhang XW; Chen T; Xia K; Yan XX; Cao L; Cai F; Pan Q; Shen L; Jiang H
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1447-9. PubMed ID: 16842693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exon deletions of parkin gene in patients with Parkinson disease.
    Wang T; Liang Z; Sun S; Cao X; Peng H; Liu H; Tong E
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(3):262-5. PubMed ID: 15315343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.
    Jankovic MZ; Dobricic V; Kresojevic N; Markovic V; Petrovic I; Svetel M; Pekmezovic T; Novakovic I; Kostic V
    J Neurol Sci; 2018 Oct; 393():27-30. PubMed ID: 30099245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.